文献速递神经康复

神经认知机器人辅助手功能康复对亚急性卒中运动恢复的随机对照试验

Neurocognitive robot-assisted rehabilitation of hand function: a randomized control trial on motor recovery in subacute stroke.
PubMed 文献 · J Neuroeng Rehabil · 2020-08-24

本研究在亚急性卒中住院患者中开展平行组随机对照试验,比较神经认知机器人辅助手功能训练与剂量匹配的常规神经认知治疗。主要结局FMA-UE在干预结束、第8周和第32周的变化显示机器人组不劣于对照组,提示该技术可用于早期手功能康复。

要点

  • 神经认知机器人辅助手功能训练在亚急性卒中患者中运动恢复不劣于剂量匹配常规治疗。
  • 机器人组与常规组FMA-UE改善分别为7.14/6.85、7.79/7.31和8.64/8.08分。

核心结论

  • 神经认知机器人辅助手功能训练在亚急性卒中住院康复中可实现不劣于剂量匹配常规神经认知治疗的运动恢复。

研究设计与样本

  • 平行组随机对照试验,纳入亚急性卒中受试者,比较常规与机器人辅助神经认知手功能治疗,使用触觉设备。
  • 治疗为4周内15次45分钟 sessions,嵌套于标准治疗程序中。

主要发现

  • 干预结束时FMA-UE改善机器人组7.14分、常规组6.85分。
  • 第8周FMA-UE改善机器人组7.79分、常规组7.31分。
  • 第32周FMA-UE改善机器人组8.64分、常规组8.08分,机器人组运动恢复不劣于对照组。

关键数值与推荐

  • 主要结局为干预后FMA-UE较基线的变化,采用等效性检验进行组间比较。
  • 次要结局包括上肢运动、感觉和认知评估、 delivered therapy dose及用户技术接受度问卷。

临床怎么用

  • 亚急性卒中住院康复中可早期引入神经认知机器人辅助手功能训练,以增加手治疗剂量。
  • 该技术可作为向临床最小治疗师监督或出院后家庭使用过渡的第一步。

局限性

  • 完成研究的样本量较小,机器人组14例、常规组13例。
  • 试验为回顾性注册。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hand function is often impaired after stroke, strongly affecting the ability to perform daily activities. Upper limb robotic devices have been developed to complement rehabilitation therapy offered to persons who suffered a stroke, but they rarely focus on the training of hand sensorimotor function. The primary goal of this study was to evaluate whether robot-assisted therapy of hand function following a neurocognitive approach (i.e., combining motor training with somatosensory and cognitive tasks) produces an equivalent decrease in upper limb motor impairment compared to dose-matched conventional neurocognitive therapy, when embedded in the rehabilitation program of inpatients in the subacute stage after stroke. METHODS: A parallel-group, randomized controlled trial was conducted on subjects with subacute stroke receiving either conventional or robot-assisted neurocognitive hand therapy using a haptic device. Therapy was provided for 15, 45-min sessions over four weeks, nested within the standard therapy program. Primary outcome was the change from baseline in the upper extremity part of the Fugl-Meyer Assessment (FMA-UE) after the intervention, which was compared between groups using equivalence testing. Secondary outcome measures included upper limb motor, sensory and cognitive assessments, delivered therapy dose, as well as questionnaires on user technology acceptance. RESULTS: Thirty-three participants with stroke were enrolled. 14 subjects in the robot-assisted and 13 subjects in the conventional therapy group completed the study. At the end of intervention, week 8 and week 32, the robot-assisted/conventional therapy group improved by 7.14/6.85, 7.79/7.31, and 8.64/8.08 points on the FMA-UE, respectively, establishing that motor recovery in the robot-assisted group is non-inferior to that in the control group. CONCLUSIONS: Neurocognitive robot-assisted therapy of hand function allows for a non-inferior motor recovery compared to conventional dose-matched neurocognitive therapy when performed during inpatient rehabilitation in the subacute stage. This allows the early familiarization of subjects with stroke to the use of such technologies, as a first step towards minimal therapist supervision in the clinic, or directly at home after hospital discharge, to help increase the dose of hand therapy for persons with stroke. TRIAL REGISTRATION: EUDAMED database (CIV-13-02-009921), clinicaltrials.gov (NCT02096445). Registered 26 March 2014 - Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02096445.

来源:J Neuroeng Rehabil,查看原文。版权归原作者所有。

引用

  1. Ranzani R, Lambercy O, Metzger JC, et al. Neurocognitive robot-assisted rehabilitation of hand function: a randomized control trial on motor recovery in subacute stroke. J Neuroeng Rehabil. 2020. PMID: 32831097. doi:10.1186/s12984-020-00746-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。